Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hemangioblastoma
100%
Vitreous
94%
Proliferative Vitreoretinopathy
88%
Posterior Vitreous Detachment
82%
Surgery
69%
Retinal Detachment
68%
Retina Tear
62%
Vitreous Hemorrhage
53%
Vitrectomy
50%
Epiretinal Membrane
40%
Trypan Blue
40%
Retinal Break
40%
Systematic Review
40%
Treatment Option
38%
Vitreoretinal Surgery
34%
Visual Acuity
33%
Cataract Surgery
30%
Injection
24%
Low Level Laser Therapy
22%
Visual Impairment
21%
Diathermy
20%
Cannulation
20%
Eye Toxicity
20%
Pediatrics Patient
20%
Endophthalmitis
20%
Placebo
20%
Dexamethasone
20%
Prevalence
20%
Agents Acting on the Eye
20%
Hamartoma
20%
Optical Coherence Tomography Angiography
20%
Central Retinal Vein Occlusion
20%
Tissue Plasminogen Activator
20%
Implant
20%
Retinal Pigment Epithelium
20%
Glaucoma
20%
Antibiotics
20%
Retinal Haemorrhage
19%
Internal Limiting Membrane
18%
Pooled Analysis
16%
Alteplase
15%
Best Corrected Visual Acuity
14%
Prospective Study
13%
Surgical Technique
13%
Laser Coagulation
12%
Tumor
12%
Logistic Regression Analysis
10%
Reproductive Medicine
10%
Postoperative Complication
10%
Odds Ratio
10%
Keyphrases
Proliferative Vitreoretinopathy
47%
Floaters
44%
Retinal Break
40%
Retinal Tear
33%
Rhegmatogenous Retinal Detachment
30%
Posterior Vitreous Detachment
28%
Retinal Detachment
26%
Hyalocytes
26%
Vitreoschisis-induced Vitreous Cortex Remnants
23%
Retinal Detachment Surgery
23%
Retinal Hemangioblastoma
20%
Vitreous Cortex Remnants
20%
Vitrectomy
20%
Forceps
20%
Retinal Surfaces
20%
Vitreoretinal Surgery
20%
Early Surgery
20%
Epiretinal Membrane
20%
Cryotherapy
20%
Laser Photocoagulation
20%
Internal Limiting Membrane
20%
Laser Therapy
20%
Late Development
20%
Fellow Eye
20%
Prophylactic Laser
20%
Combined Hamartoma
20%
Vitreoretinal Diseases
20%
10-year Follow-up
20%
Trypan Blue Staining
20%
Superiority Trial
20%
Prospective multicenter
20%
Technical Protocols
20%
Warning Signs
20%
Acute Onset
20%
Retinopexy
20%
Randomized Clinical Trial
20%
Ocular Toxicity Studies
20%
Surgical Failure
16%
Trypan Blue
15%
Consecutive Patients
13%
Macula-off
11%
Surgical Technique
10%
Visual Recovery
10%
Live Animal
10%
Tumor Eradication
10%
System Technique
10%
Pooled Analysis
10%
Curtain
10%
Macular Hole
7%
Macular Pucker
7%